Houston, Texas 77030


The investigators have previously reported that older patients with HIV are deficient in glutathione (GSH) due to decreased availability of cysteine and glycine, and that oral supplementation with cysteine (as n-acetylcysteine) and glycine for 2-weeks corrects their own levels, and improves concentrations of red-cell GSH. The investigators also found that when GSH deficient, subjects had impaired mitochondrial energetics and this improved with an increase in intracellular GSH concentrations. The current proposal will investigate if cysteine and glycine supplementation for a duration of 24 weeks will result in changes in : (a) GSH levels; (b) body composition/anthropometry; (c) strength and function; (d) quality of life; (e) mitochondrial energetics; (f) biochemistry (including dyslipidemia and oxidative stress); (g) protein and glucose metabolism; (h) cognition and memory. 3 months after completing supplementation, measurement of GSH concentrations, strength, function, mitochondrial energetics and neurocognitive tests will be done to determine the effects of washout.

Study summary:

Data not available at present


Inclusion Criteria: Older subjects: - age 70-80 years; Younger subjects: - age 21-30 years Exclusion Criteria: 1. No known diabetes, liver disease, kidney disease, coronary heart disease, stroke, or cancer; 2. Any limitations in ability to walk; 3. Triglyceride concentrations greater than 500 mg/dl (if lipid lowering medications are stopped); 4. BMI less than 20.



Primary Contact:

Principal Investigator
R V Sekhar, M.D.
Baylor College of Medicine

R V Sekhar, M.D.
Phone: 7137983908
Email: rsekhar@bcm.edu

Backup Contact:


Location Contact:

Houston, Texas 77030
United States

R V Sekhar, M.D.

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.